Biotest Aktiengesellschaft Financial Flexibility Index
Biotest Aktiengesellschaft financial flexibility index. Biotest Aktiengesellschaft (BIO) has a Financial Flexibility Index of -0.06x as of March 2025. Free cash flow of €-58.10 Million (operating CF €-58.10 Million minus capex €0.00) represents 0% of total liabilities (€906.90 Million). See Biotest Aktiengesellschaft free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Biotest Aktiengesellschaft (2002–2024)
Financial flexibility index of Biotest Aktiengesellschaft from 2002 to 2024. Historical Financial Flexibility Index trend for Biotest Aktiengesellschaft across 23 annual periods. Check BIO operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Biotest Aktiengesellschaft Financial Flexibility Index by Year (2002–2024)
Biotest Aktiengesellschaft financial flexibility index by year from 2002 to 2024. Year-by-year free cash flow to debt coverage for Biotest Aktiengesellschaft. For the full cash flow conversion analysis, see Biotest Aktiengesellschaft cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.10x | €89.60 Million | €60.90 Million | €903.30 Million | ▲ +194.7% |
| 2023 | 0.03x | €30.70 Million | €-2.70 Million | €912.00 Million | ▲ +350.0% |
| 2022 | -0.01x | €-11.20 Million | €-40.50 Million | €831.90 Million | ▼ -118.7% |
| 2021 | 0.07x | €52.10 Million | €33.90 Million | €723.80 Million | ▲ +382.0% |
| 2020 | 0.01x | €10.30 Million | €-16.70 Million | €689.70 Million | ▲ +1786.2% |
| 2019 | 0.00x | €500.00K | €-33.60 Million | €631.50 Million | ▼ -90.6% |
| 2018 | 0.01x | €4.60 Million | €-50.00 Million | €547.10 Million | ▼ -96.2% |
| 2017 | 0.22x | €140.80 Million | €34.30 Million | €630.70 Million | ▼ -39.1% |
| 2016 | 0.37x | €209.80 Million | €65.90 Million | €572.10 Million | ▲ +45.4% |
| 2015 | 0.25x | €138.80 Million | €38.10 Million | €550.40 Million | ▲ +318.3% |
| 2014 | 0.06x | €33.30 Million | €-11.40 Million | €552.40 Million | ▼ -28.1% |
| 2013 | 0.08x | €35.70 Million | €-7.20 Million | €425.80 Million | ▼ -62.1% |
| 2012 | 0.22x | €69.23 Million | €34.73 Million | €312.91 Million | ▼ -24.9% |
| 2011 | 0.29x | €98.99 Million | €72.28 Million | €336.09 Million | ▼ -10.8% |
| 2010 | 0.33x | €107.20 Million | €77.83 Million | €324.73 Million | ▲ +67.1% |
| 2009 | 0.20x | €71.85 Million | €31.68 Million | €363.59 Million | ▼ -5.8% |
| 2008 | 0.21x | €71.03 Million | €34.49 Million | €338.67 Million | ▲ +100.6% |
| 2007 | 0.10x | €32.51 Million | €32.51 Million | €310.94 Million | ▼ -22.6% |
| 2006 | 0.14x | €26.31 Million | €26.31 Million | €194.69 Million | ▼ -5.5% |
| 2005 | 0.14x | €28.32 Million | €28.32 Million | €198.12 Million | ▼ -18.5% |
| 2004 | 0.18x | €43.91 Million | €25.29 Million | €250.31 Million | ▲ +16.9% |
| 2003 | 0.15x | €37.03 Million | €16.52 Million | €246.69 Million | ▲ +17.9% |
| 2002 | 0.13x | €33.26 Million | €2.46 Million | €261.20 Million | — |